Temple Lung Center at ATS 2026: Conference Recap - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Temple Lung Center at ATS 2026: Conference Recap

The American Thoracic Society's 2026 International Conference brought together leading voices in pulmonary, critical care, and sleep medicine — and Temple Health was well represented.

  • By

  • June 1, 2026

  • 7 min

Share

Clinical Scorecard: Temple Lung Center at ATS 2026: Conference Recap

At a Glance

CategoryDetail
ConditionChronic Obstructive Pulmonary Disease (COPD) and related pulmonary conditions
Key MechanismsEmerging therapies and diagnostic strategies in pulmonary medicine
Target PopulationPatients with COPD, interstitial lung disease, and pulmonary hypertension
Care SettingPulmonary, critical care, and sleep medicine

Key Highlights

  • Pooled results indicate mepolizumab reduces COPD exacerbations requiring hospitalization.
  • Elevated eosinophil counts near conception predict asthma exacerbations during pregnancy.
  • Inhaled treprostinil significantly preserves lung function in adults with idiopathic pulmonary fibrosis.
  • Higher corticosteroid doses associated with shorter hospitalization in AE-SARD-ILD survivors.
  • Pre-procedural CT analysis identifies risk factors for pneumothorax after bronchoscopic lung volume reduction.

Guideline-Based Recommendations

Diagnosis

  • Consider eosinophil counts for predicting asthma exacerbations during pregnancy.

Management

  • Mepolizumab as an add-on therapy for COPD patients with elevated eosinophil counts.

Monitoring & Follow-up

  • Utilize 6-minute walk testing to predict exacerbations in COPD patients.

Risks

  • Identify disparities in access and survival rates in SARD-ILD patients.

Patient & Prescribing Data

Patients with COPD, interstitial lung disease, and pulmonary hypertension

Sotatercept shows potential in improving clinical outcomes in Group 3 pulmonary hypertension.

Clinical Best Practices

  • Monitor inflammatory biomarkers in COPD exacerbations.
  • Evaluate lung function preservation strategies in IPF patients.

Related Resources & Content

    Original Source(s)

    Temple Lung Center at ATS 2026: Conference Recap

    • by

    • June 1, 2026

    Related Content

    AI-Assisted MRI Method May Rival CT in Lung Nodule Detection

    A rapid AI‐assisted imaging protocol detected nearly all clinically relevant solid lung nodules while closely matching CT for suspicious screening classifications.

    Do Sitting Patterns Matter?

    Researchers analyzed UK Biobank data to determine whether spending sedentary time in prolonged vs interrupted bouts was associated with subsequent cancer incidence and cancer mortality.

    Conservative management of < 3cm anterior mediastinal lesions in lung cancer screening is safe